Human papillomavirus (HPV) affects hundreds of millions of people worldwide and is
associated with both benign and malignant neoplasms in men and women. It is a double …

Vaccination against human papillomavirus (HPV) is safe and effective. It is recommended for
females age 9 to 26 and for males age 11 to 26, yet vaccination rates are low. We review the …

This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …

Key Clinical Points Human Papillomavirus Vaccination Human papillomavirus (HPV) is a
common sexually transmitted virus. Most HPV infections clear or become undetectable …

Background Human papillomavirus (HPV) infections are associated with common
dermatologic and nondermatologic diseases. Although HPV vaccines are well established …

Current status of human papillomavirus vaccination : Current Opinion in Oncology Current status
of human papillomavirus vaccination : Current Opinion in Oncology Log in or Register Subscribe …

The casual relationship concerning Human papillomaviruses (HPV) and cervical cancer is
already established. Therefore, such HPV-associated malignancies might be prevented by …

Genital human papillomavirus (HPV) infection and HPV‐associated cervical and other
anogenital cancers are significant public health problems. HPV 16 and HPV 18 are …

The link between human papillomavirus (HPV) infection and different diseases has been
well-established since more than four decades ago [1, 2]. Moreover, high-risk HPV types …

It is critical for pediatricians to thoroughly understand HPV biology and disease and
champion HPV vaccination to prevent cervical, vulvar, and vaginal cancers, even though …